- Skill Level
What you'll learn
In this course, you can learn about dendritic cell vaccination in cancer patients. You will see the process of in vitro optimization of dendritic cells which can be prepared from peripheral blood of cancer patients in a faster, more effective, and safe way. read more »»
Key concepts covered include:
“By the end of this course, you’ll be able to understand:
- From preclinical to clinical research in optimization of dendritic cells suitable for anti-cancer vaccination and a broad clinical experience with it.”
20 years of experience in regenerative medicine, stem cell therapy, anti-cancer immunotherapy. Board-certified in Immunology, Oncology, Pediatrics. Prof. He has 16 years of experience in regenerative medicine and cell therapy. He is a president of the International Consortium for Cell Therapy and Immunotherapy and also holds the European patent for the isolation of stem cells from adipose and connective tissue. He is the author of more than 200 scientific publications, he has regularly lectured at domestic and international conferences. In 2010 prof. Michalek founded the Cellthera Clinic focusing on the use of adipose-derived stem cells in regenerative medicine.